Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • AXP vs MRNA✓SelectedUSD · MRNAAXP vs MRNA performance historyLatest closeAs of-1.02%11/17
Stock and ETF performance explorer

AXP vs MRNA

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+86.9%
MRNA return
-11.9%
Excess return
+98.9%
Maximum drawdown
-31.5%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 5y.

Portfolio and benchmark returns by period
PeriodPortfolioMRNAExcessAlpha
1D-1.0%-3.9%+2.9%-0.9%
7D-2.4%-17.6%+15.2%-1.6%
30D+0.7%-5.1%+5.8%+0.8%
3M-5.8%+220.8%-226.6%-13.9%
6M+1.3%+321.7%-320.4%-10.6%
YTD-13.7%+601.3%-614.9%-28.6%
1Y-6.4%+735.2%-741.6%-24.2%
3Y+100.9%+170.5%-69.6%+73.2%
5Y+86.9%-14.6%+101.6%+60.1%
All+86.9%-11.9%+98.9%+60.1%

Cumulative growth

Daily Returns

Daily percentage return beside MRNA.

Daily Out/Under-Performance

Portfolio return minus MRNA return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × MRNA return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 5y: compounded portfolio wealth divided by compounded MRNA wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

5y analysis · Full analysis span regression · 6 months rolling